Dividend
-
-
-
-
-
-
-
Abbott declares 409th consecutive quarterly dividend
-
-
-
-
-
-
-
Abbott Reports Second-Quarter 2025 Results
-
-
-
-
-
-
-
Cadrenal Therapeutics Reports Full Year 2024 Results, Business Highlights, and Path Forward for Clinical Advancement of Tecarfarin
-
-
-
-
-
-
-
Abbott Increases Quarterly Dividend for 53rd Consecutive Year
-
-
-
-
-
-
-
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
-
-
-
-
-
-
-
Abbott (ABT) Declares $0.51 Quarterly Dividend; 2% Yield
-
-
-
-
-
-
-
Abbott Declares 397th Consecutive Quarterly Dividend
-
447,469 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

